Previous 10 |
MedTech Acquisition (MTAC) has received a non-compliance notice from the Nasdaq Stock Market as a result of its failure to file its quarterly report for the period ended March 31, 2021 on time.The company will have 60 calendar days, or until July 26, 2021, to submit a plan to regain comp...
New York, NY, June 02, 2021 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTACU) (the “Company”) today announced that it has received a notice (“Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”)...
Robotic-surgery firm Memic Innovative Surgery is said in talks to go public through a deal with SPAC Med Tech Acquisition Corp. (MTAC)Terms of the deal couldn't immediately be learned, according to a Bloomberg report.Memic closed a $96M Series D financing round in April, which...
News, Short Squeeze, Breakout and More Instantly...
MedTech Acquisition Corporation Company Name:
MTAC Stock Symbol:
NASDAQ Market:
MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company”) today announced that it convened and then adjourned, without conducting any business, its special meeting of stockholders (the “Special Meeting”). The Special Meeting is being hel...
New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment and decreased circulating tumor DNA (ctDNA) levels TriSalus Life Sciences® Inc., (TriSalus or the Company), an oncology company in the process of going publi...
TriSalus Life Sciences ® , Inc. (“TriSalus” or the “Company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with MedTech Acquisition Corporation (Nasdaq: MTAC) (“...